Biosovereignty Doctrine Accountability Governance.
1. Meaning
Biosovereignty Doctrine Accountability Governance is a proposed interdisciplinary legal and governance framework addressing who has the authority to control, regulate, access, use, protect, and make decisions about biological resources and biological information.
It brings together three connected concepts:
Biosovereignty doctrine: The legal and ethical principles governing authority over biological resources, human biological materials, genetic information, biodiversity, and biotechnology.
Accountability: The obligation of governments, corporations, researchers, laboratories, and other institutions to justify their decisions, comply with legal standards, prevent harm, and provide remedies for violations.
Governance: The institutional arrangements, laws, regulatory bodies, oversight mechanisms, and public participation processes through which biological resources and technologies are managed.
Important legal clarification: “Biosovereignty Doctrine Accountability Governance” is not, by itself, a universally recognized or codified legal doctrine with a single binding definition. It is best understood as an analytical framework constructed from established principles of constitutional law, environmental law, bioethics, public health law, human rights, and international biodiversity law.
The central question is:
Who should exercise authority over biological resources and technologies, under what legal limits, and how can that authority be held accountable?
2. Scope of the doctrine
Whitney Laboratory for Marine Science | University of Florida
A. Human biological autonomy
Covers genetic data, human tissue, biological samples, reproductive technologies, medical research, informed consent, privacy, and protection against genetic discrimination.
B. Biodiversity and genetic resources
Addresses access to genetic resources, traditional knowledge, benefit-sharing, conservation, and the rights and interests of Indigenous peoples and local communities.
IT Solutions for Biotech and Pharma Industry | Virtusa
C. Biotechnology and biosecurity
Concerns genetic engineering, synthetic biology, laboratory safety, biological risk management, dual-use research, and the lawful oversight of potentially dangerous technologies.
D. Public health and state power
Examines vaccination policies, disease surveillance, quarantine, emergency health measures, and the balance between collective protection and individual liberty.
These categories overlap, but their governing legal rules differ. State sovereignty over natural resources, for example, does not automatically establish ownership over a person's body, cells, or genetic identity.
3. Core principles of biosovereignty accountability governance
3.1 Sovereignty subject to law
States have sovereign rights over natural resources within their jurisdiction, but that authority is constrained by domestic constitutional law, applicable international obligations, and duties to prevent environmental harm.
Article 3 of the Convention on Biological Diversity (CBD) recognizes states' sovereign rights to exploit their own resources pursuant to their environmental policies, together with responsibility to ensure that activities under their jurisdiction or control do not damage the environment of other states or areas beyond national jurisdiction.
EUR-Lex
This means sovereignty is a source of regulatory authority, not an unlimited power to disregard individual rights or ecological responsibilities.
3.2 Human dignity and biological autonomy
Human genetic information, DNA samples, and medical records may reveal highly personal information. Decisions to collect, analyze, store, or share them therefore raise questions of consent, privacy, confidentiality, and bodily autonomy.
In India, Article 21 of the Constitution protects life and personal liberty, while the right to privacy is a constitutionally protected fundamental right. The precise restrictions on biological-data processing depend on the applicable legislation and circumstances.
Indian Kanoon+1
3.3 Accountability for biological decisions
An institution exercising biological authority should be able to demonstrate:
Legal authorization for its actions.
Scientific evidence supporting its decisions.
Proportionate measures to manage risks.
Transparent procedures and reliable records.
Independent oversight and conflict-of-interest safeguards.
Access to complaints, judicial review, and appropriate remedies.
3.4 Fair and equitable benefit-sharing
Where genetic resources or associated traditional knowledge are utilized commercially or scientifically, applicable access-and-benefit-sharing rules may require permits, mutually agreed terms, and benefit-sharing arrangements.
The Nagoya Protocol provides an international framework for fair and equitable sharing of benefits from the utilization of genetic resources and associated traditional knowledge.
Convention on Biological Diversity+1
3.5 Precaution and biological safety
When biotechnology or biological materials may create serious risks, governance should include appropriate risk assessment, containment, monitoring, emergency planning, and regulatory review. Precaution does not mean automatically prohibiting every new technology; it means taking risks seriously even when scientific knowledge is incomplete.
The Cartagena Protocol on Biosafety specifically addresses the safe handling, transport, and use of living modified organisms that may adversely affect biodiversity, while taking human-health risks into account.
Biosafety Clearing-House+1
4. Major case laws relevant to biosovereignty
Because the term itself is not a settled legal doctrine, the following judgments are analogous authorities. They establish principles that can support particular aspects of biosovereignty governance; they do not all directly decide a case under that name.
Case 1: Justice K.S. Puttaswamy (Retd.) v. Union of India (2017)
Citation: (2017) 10 SCC 1; 2017 INSC 801
Court: Supreme Court of India.
Facts and issue: The case concerned whether privacy is a fundamental right under the Indian Constitution, arising in the context of the Aadhaar identification scheme.
Judgment: The nine-judge bench unanimously recognized privacy as a constitutionally protected fundamental right, grounded in liberty, dignity, and personal autonomy.
Relevance to biosovereignty accountability:
Biological and genetic information can implicate privacy and personal autonomy.
Government collection and processing of sensitive biological data should have a lawful basis and appropriate safeguards.
Restrictions must satisfy constitutional standards, including legality, a legitimate state purpose, and proportionality.
Public authorities must be answerable for unjustified intrusions into protected rights.
Legal significance: This judgment supplies a major constitutional foundation for accountability in genetic databases, biometric identification, medical-data processing, and other systems that handle intimate personal information. It does not, by itself, determine ownership of all biological samples.
Indian Kanoon+1
Case 2: Vellore Citizens’ Welfare Forum v. Union of India (1996)
Citation: (1996) 5 SCC 647; AIR 1996 SC 2715
Court: Supreme Court of India.
Facts: Tanneries in Tamil Nadu discharged untreated effluents, causing serious environmental pollution and damage to agricultural land and water resources.
Judgment: The Court recognized the precautionary principle and the polluter-pays principle as essential features of sustainable development in Indian environmental law. It required mechanisms for compensation and ecological restoration.
Indian Kanoon+1
Relevance to biosovereignty governance:
Biological resources must be managed with attention to ecological integrity.
Industries and other responsible actors may be required to bear the costs of environmental damage.
Regulators must act to prevent serious environmental harm rather than simply respond after it occurs.
Scientific uncertainty does not automatically justify inaction where there is a credible threat of serious or irreversible harm.
Legal significance: This decision provides a foundation for environmental accountability in biotechnology, biological-waste management, and activities threatening biodiversity. Its principles must be applied in the relevant statutory and factual context.
Case 3: Moore v. Regents of the University of California (1990)
Citation: 51 Cal. 3d 120; 793 P.2d 479
Court: Supreme Court of California, United States.
Facts: John Moore alleged that his physician used his cells in research that led to a commercially valuable cell line without adequately disclosing the physician's research and financial interests.
Judgment: The Court rejected Moore's conversion claim concerning the cells but allowed claims based on breach of fiduciary duty and lack of informed consent to proceed. The decision therefore did not establish a general right to share in every commercial benefit derived from human tissue.
Justia Law+1
Relevance to biosovereignty accountability:
Researchers and physicians should disclose material research interests when obtaining consent.
The collection of a biological sample for treatment does not necessarily authorize every unrelated research use.
Institutional accountability can arise through duties of disclosure and informed consent even where property-law remedies are unavailable.
Legal significance: Moore illustrates the tension between bodily autonomy, research freedom, commercial innovation, and ownership claims over biological materials. It is a US state-law decision, not binding precedent in India.
Case 4: Association for Molecular Pathology v. Myriad Genetics, Inc. (2013)
Citation: 569 U.S. 576 (2013)
Court: Supreme Court of the United States.
Facts: The dispute concerned patents on the BRCA1 and BRCA2 genes, variants of which are associated with increased breast and ovarian cancer risks.
Judgment: The Court held that naturally occurring DNA segments are not patent-eligible merely because they have been isolated. It distinguished complementary DNA (cDNA), which it generally regarded as patent-eligible because it is not naturally occurring in the same form.
LII / Legal Information Institute+1
Relevance to biosovereignty governance:
Discovering naturally occurring biological information does not automatically confer an exclusive patent right over that information.
Patent examination must distinguish discoveries of nature from qualifying human-made inventions.
Access to genetic testing and the boundaries of biotechnology monopolies are important governance concerns.
Legal significance: Myriad helps explain how patent law limits certain forms of private control over genetic material. It does not establish public ownership of all genetic resources or prohibit patents on every biotechnology-related invention.
Case 5: Divya Pharmacy v. Union of India (2018)
Court: Uttarakhand High Court, India
Legal issue: Whether domestic companies using biological resources sourced from India could be subject to benefit-sharing obligations under India's biodiversity framework, including questions involving access by Indian entities.
Significance: The litigation concerned the relationship between domestic commercial use of biological resources and benefit-sharing obligations under the Biological Diversity Act, 2002, as it then stood.
Relevance to biosovereignty accountability:
Commercial exploitation of biological resources can raise obligations beyond ordinary property and contract law.
Benefit-sharing rules can support conservation and fairer distribution of economic benefits.
Regulatory decisions must be grounded in the applicable statutory provisions and the scope of the authority's powers.
Caution: The exact scope of benefit-sharing obligations must be assessed under the legislation applicable at the relevant time, including subsequent amendments and implementing rules. The case should not be read as establishing an unrestricted government right over every biological product.
The Court upheld the legality of the challenged benefit-sharing framework in the context of the dispute. The case is particularly relevant because it connects biological sovereignty with statutory accountability, commercial utilization, and the interests of communities that conserve biological resources.
abs.nls.ac.in+2
Case 6: M.C. Mehta v. Union of India — environmental accountability jurisprudence
Court: Supreme Court of India; a series of cases rather than one single judgment.
Principle: The Court's environmental jurisprudence has developed constitutional protection against environmental degradation, regulatory duties, and the accountability of enterprises responsible for harmful activities.
Relevance: Where biological-resource exploitation threatens ecosystems, public health, or biodiversity, the government may be required to enforce environmental safeguards. The specific remedy depends on the applicable law and the facts.
This line of cases complements Vellore Citizens' Welfare Forum by demonstrating how environmental protection can be enforced through constitutional and statutory mechanisms.
5. Indian statutory framework
In India, the most direct statutory framework for the biodiversity aspect of biosovereignty is the Biological Diversity Act, 2002, as amended by the Biological Diversity (Amendment) Act, 2023. The amended regime must be read alongside the applicable rules and regulations.
IndiaCode+1
| Legal instrument | Governance function |
|---|---|
| Constitution of India, Article 21 | Protection of life, personal liberty, and privacy-related interests |
| Articles 48A and 51A(g) | Environmental protection and citizens' environmental duties |
| Biological Diversity Act, 2002, as amended | Conservation, sustainable use, access regulation, and benefit-sharing |
| Biological Diversity Rules, 2024, and applicable amendments | Implementation of the statutory framework |
| Applicable access-and-benefit-sharing regulations | Conditions and procedures governing covered utilization of biological resources |
| Digital Personal Data Protection Act, 2023, where applicable | Regulation of covered digital personal-data processing |
| Patents Act, 1970, and applicable patent law | Patentability, including relevant restrictions concerning biological inventions |
The National Biodiversity Authority performs regulatory, advisory, and facilitative functions under the biodiversity framework. Benefit-sharing requirements depend on the resource, activity, person concerned, exemptions, and applicable statutory provisions.
National Biodiversity Authority+2
Key governance institutions
National Biodiversity Authority (NBA): Relevant approvals, access regulation, and benefit-sharing functions.
State Biodiversity Boards: State-level regulatory functions under the Act.
Biodiversity Management Committees: Local biodiversity governance and participation.
Courts and the National Green Tribunal: Review and enforcement within their respective jurisdictions.
Research ethics committees and relevant scientific regulators: Oversight of covered biomedical research, safety, and ethical compliance.
6. Accountability mechanisms under the doctrine
A workable biosovereignty governance framework should provide accountability at six levels.
1. Legal accountability
Every exercise of biological regulatory power must have a valid legal basis. Authorities should act within their statutory jurisdiction, provide reasons where required, and comply with procedural fairness.
2. Ethical accountability
Covered human-subject research should follow applicable consent, confidentiality, ethics-review, and participant-protection requirements.
3. Scientific accountability
Decisions involving biological risk should use defensible evidence, independent assessment where appropriate, documented methods, and continuing safety monitoring.
4. Community accountability
Governance should respect applicable community rights, traditional knowledge, participation requirements, and benefit-sharing arrangements.
5. Transparency and auditability
Appropriate records should document permissions, sample transfers, access to genetic data, safety incidents, financial interests, and benefit-sharing obligations.
6. Remedial accountability
Depending on the violation, available remedies may include judicial review, compensation, penalties, suspension of authorization, restoration of ecological damage, or corrective measures.
7. Practical application: a hypothetical case
Suppose a biotechnology company collects medicinal plants and associated traditional knowledge from an Indian community, extracts commercially valuable compounds, and develops a profitable medicine without complying with applicable access-and-benefit-sharing obligations.
The biosovereignty accountability analysis would proceed as follows:
Identify the resource: Determine which biological resources and traditional knowledge were accessed and how they were obtained.
Determine applicable law: Establish whether the Biological Diversity Act and its implementing instruments apply, including relevant exemptions.
Review authorization: Examine whether required approvals, registrations, notifications, or other procedures were followed.
Assess community interests: Identify relevant benefit claimers and any applicable consent, consultation, or benefit-sharing requirements.
Investigate responsibility: Establish the roles of the company, researchers, intermediaries, and relevant authorities.
Determine remedies: Apply available statutory or judicial remedies, potentially including benefit-sharing, penalties, or other corrective action.
The Divya Pharmacy judgment is a particularly relevant Indian authority for the benefit-sharing dimension. The Nagoya Protocol provides the corresponding international framework for covered genetic resources and associated traditional knowledge.
abs.nls.ac.in+1
8. Constitutional limits and potential conflicts
Biosovereignty is not synonymous with absolute state ownership or unrestricted regulatory control. Its exercise can create tensions between:
National control over biological resources and international scientific cooperation.
Commercial innovation and equitable sharing of benefits.
Public-health protection and individual privacy.
Biological security and legitimate scientific freedom.
Conservation objectives and the customary practices of local communities.
A sound legal framework should require lawful authority, proportionality where fundamental rights are restricted, fair procedures, scientifically justified regulation, and effective remedies.
For instance, a government cannot justify indiscriminate collection of citizens' genetic data merely by invoking national biological sovereignty. The constitutional analysis must separately examine the legal basis, legitimate objective, scope of the intrusion, safeguards, and proportionality under the applicable law.
9. Conclusion
Biosovereignty Doctrine Accountability Governance is best understood as a proposed legal framework for ensuring that authority over biological resources, human biological information, and biotechnology is exercised responsibly.
Its strongest established legal foundations are:
Constitutional privacy and personal autonomy, particularly under Puttaswamy.
Environmental precaution and polluter accountability, particularly under Vellore Citizens' Welfare Forum.
Disclosure and informed-consent duties in human-tissue research, illustrated by Moore.
Limits on patents over naturally occurring genetic material, illustrated by Myriad Genetics.
Biodiversity regulation and fair benefit-sharing, illustrated by Divya Pharmacy and the Nagoya Protocol.
Taken together, these authorities support a framework in which biological authority is constrained by law, scientific responsibility, human dignity, ecological protection, transparency, and fair distribution of benefits.
The important qualification is that these principles arise from distinct legal regimes; they do not collectively establish a single, universally binding biosovereignty doctrine. Any real dispute must be resolved under the specific constitutional provisions, statutes, treaties, and precedents applicable to its facts.
RELATED Blog
comments